Depression Drugs Market Report by Drug Class (Atypical Antipsychotics, Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Selective Serotonin Reuptake Inhibitors (SSRIs), Central Nervous System (CNS) Stimulants, Tricyclic Antidepressants, Monoamine Oxidase Inhibitors, and Others), Disorder Type (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, and Others), Drug Type (Generic Drugs, Branded Drugs), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Region 2024-2032

Depression Drugs Market Report by Drug Class (Atypical Antipsychotics, Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Selective Serotonin Reuptake Inhibitors (SSRIs), Central Nervous System (CNS) Stimulants, Tricyclic Antidepressants, Monoamine Oxidase Inhibitors, and Others), Disorder Type (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, and Others), Drug Type (Generic Drugs, Branded Drugs), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A1563
Buy Now

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Depression Drugs Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Breakup by Drug Class
    5.5    Market Breakup by Disorder Type
    5.6    Market Breakup by Drug Type
    5.7    Market Breakup by Distribution Channel
    5.8    Market Breakup by Region
    5.9    Market Forecast
6   Market Breakup by Drug Class
    6.1    Atypical Antipsychotics 
        6.1.1    Market Trends
        6.1.2    Market Forecast
    6.2    Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
        6.2.1    Market Trends
        6.2.2    Market Forecast
    6.3    Selective Serotonin Reuptake Inhibitors (SSRIs)
        6.3.1    Market Trends
        6.3.2    Market Forecast
    6.4    Central Nervous System (CNS) Stimulants
        6.4.1    Market Trends
        6.4.2    Market Forecast
    6.5    Tricyclic Antidepressants
        6.5.1    Market Trends
        6.5.2    Market Forecast
    6.6    Monoamine Oxidase Inhibitors
        6.6.1    Market Trends
        6.6.2    Market Forecast
    6.7    Others
        6.7.1    Market Trends
        6.7.2    Market Forecast
7   Market Breakup by Disorder Type
    7.1    Major Depressive Disorder
        7.1.1    Market Trends
        7.1.2    Market Forecast
    7.2    Obsessive-Compulsive Disorder
        7.2.1    Market Trends
        7.2.2    Market Forecast
    7.3    Generalized Anxiety Disorder
        7.3.1    Market Trends
        7.3.2    Market Forecast
    7.4    Panic Disorder 
        7.4.1    Market Trends
        7.4.2    Market Forecast
    7.5    Others 
        7.5.1    Market Trends
        7.5.2    Market Forecast
8   Market Breakup by Drug Type
    8.1    Generic Drugs
        8.1.1    Market Trends
        8.1.2    Market Forecast
    8.2    Branded Drugs
        8.2.1    Market Trends
        8.2.2    Market Forecast
9   Market Breakup by Distribution Channel
    9.1    Hospital Pharmacies
        9.1.1    Market Trends
        9.1.2    Market Forecast
    9.2    Retail Pharmacies
        9.2.1    Market Trends
        9.2.2    Market Forecast
    9.3    Online Pharmacies
        9.3.1    Market Trends
        9.3.2    Market Forecast
    9.4    Others
        9.4.1    Market Trends
        9.4.2    Market Forecast
10  Market Breakup by Region
    10.1    North America
        10.1.1    Market Trends
        10.1.2    Market Forecast
    10.2    Europe
        10.2.1    Market Trends
        10.2.2    Market Forecast
    10.3    Asia Pacific
        10.3.1    Market Trends
        10.3.2    Market Forecast
    10.4    Middle East and Africa
        10.4.1    Market Trends
        10.4.2    Market Forecast
    10.5    Latin America
        10.5.1    Market Trends
        10.5.2    Market Forecast
11  SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12  Value Chain Analysis
13  Porter’s Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Price Analysis
15  Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Otsuka Pharmaceutical
        15.3.2    Pfizer
        15.3.3    Eli Lilly and Company
        15.3.4    AstraZeneca
        15.3.5    Novartis
        15.3.6    Bristol-Myers Squibb
        15.3.7    GlaxoSmithKline
        15.3.8    Takeda Pharmaceutical Company
        15.3.9    Allergan
        15.3.10   Johnson & Johnson
        15.3.11   Zhejiang NHU Company Ltd
        15.3.12   Sebela Pharmaceuticals

List of Figures

Figure 1: Global: Depression Drugs Market: Major Drivers and Challenges
Figure 2: Global: Depression Drugs Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Depression Drugs Market: Breakup by Drug Class (in %), 2023
Figure 4: Global: Depression Drugs Market: Breakup by Disorder Type (in %), 2023
Figure 5: Global: Depression Drugs Market: Breakup by Drug Type (in %), 2023
Figure 6: Global: Depression Drugs Market: Breakup by Distribution Channel (in %), 2023
Figure 7: Global: Depression Drugs Market: Breakup by Region (in %), 2023
Figure 8: Global: Depression Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 9: Global: Depression Drugs Industry: SWOT Analysis
Figure 10: Global: Depression Drugs Industry: Value Chain Analysis
Figure 11: Global: Depression Drugs Industry: Porter’s Five Forces Analysis
Figure 12: Global: Depression Drugs (Atypical Antipsychotics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Depression Drugs (Atypical Antipsychotics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Depression Drugs (Serotonin-Norepinephrine Reuptake Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Depression Drugs (Serotonin-Norepinephrine Reuptake Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Depression Drugs (Selective Serotonin Reuptake Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Depression Drugs (Selective Serotonin Reuptake Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Depression Drugs (Central Nervous System (CNS) Stimulants) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Depression Drugs (Central Nervous System (CNS) Stimulants) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Depression Drugs (Tricyclic Antidepressants) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Depression Drugs (Tricyclic Antidepressants) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Depression Drugs (Monoamine Oxidase Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Depression Drugs (Monoamine Oxidase Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Depression Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Depression Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Depression Drugs (Major Depressive Disorder) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Depression Drugs (Major Depressive Disorder) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Depression Drugs (Obsessive-Compulsive Disorder) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Depression Drugs (Obsessive-Compulsive Disorder) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Depression Drugs (Generalized Anxiety Disorder) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Depression Drugs (Generalized Anxiety Disorder) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Depression Drugs (Panic Disorder) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Depression Drugs (Panic Disorder) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: Depression Drugs (Other Disorder Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: Depression Drugs (Other Disorder Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Global: Depression Drugs (Generic Drugs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Global: Depression Drugs (Generic Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Global: Depression Drugs (Branded Drugs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Global: Depression Drugs (Branded Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Global: Depression Drugs Market: Sales through Hospital Pharmacies (in Million US$), 2018 & 2023
Figure 41: Global: Depression Drugs Market Forecast: Sales through Hospital Pharmacies (in Million US$), 2024-2032
Figure 42: Global: Depression Drugs Market: Sales through Retail Pharmacies (in Million US$), 2018 & 2023
Figure 43: Global: Depression Drugs Market Forecast: Sales through Retail Pharmacies (in Million US$), 2024-2032
Figure 44: Global: Depression Drugs Market: Sales through Online Pharmacies (in Million US$), 2018 & 2023
Figure 45: Global: Depression Drugs Market Forecast: Sales through Online Pharmacies (in Million US$), 2024-2032
Figure 46: Global: Depression Drugs Market: Sales through Other Distribution Channels (in Million US$), 2018 & 2023
Figure 47: Global: Depression Drugs Market Forecast: Sales through Other Distribution Channels (in Million US$), 2024-2032
Figure 48: North America: Depression Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: North America: Depression Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Europe: Depression Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Europe: Depression Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Asia Pacific: Depression Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Asia Pacific: Depression Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Middle East and Africa: Depression Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Middle East and Africa: Depression Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Latin America: Depression Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Latin America: Depression Drugs Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

Table 1: Global: Depression Drugs Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Depression Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
Table 3: Global: Depression Drugs Market Forecast: Breakup by Disorder Type (in Million US$), 2024-2032
Table 4: Global: Depression Drugs Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
Table 5: Global: Depression Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 6: Global: Depression Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Depression Drugs Market Structure
Table 8: Global: Depression Drugs Market: Key Players

Depression Drugs Market Report by Drug Class (Atypical Antipsychotics, Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Selective Serotonin Reuptake Inhibitors (SSRIs), Central Nervous System (CNS) Stimulants, Tricyclic Antidepressants, Monoamine Oxidase Inhibitors, and Others), Disorder Type (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, and Others), Drug Type (Generic Drugs, Branded Drugs), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More